Comparison of diagnostic methods for detection of BRAFV600E mutation in ameloblastoma.

Arularasan AnbinselvamAbdul-Warith O Akinshipo Akinyele Olumuyiwa Adisa Olajumoke A EffiomXinhe ZhuKehinde E Adebiyi Godwin T Arotiba Sunday O Akintoye

Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2024)

Low-cost and less vulnerability of IHC to tissue quality make it a viable surrogate test for BRAFV600E detection in ameloblastoma. Sequential dual IHC and molecular testing for BRAFV600E will reduce equivocal results that could exclude some patients from BRAFV600E-inhibitor therapies.

Keyphrases

low cost
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
loop mediated isothermal amplification
peritoneal dialysis
climate change
label free
real time pcr
prognostic factors
patient reported outcomes
sensitive detection